- Advanced Human Imaging (AHI) is pushing ahead with a planned NASDAQ listing, after filing a Form F-1 with the US Securities and Exchange Commission (SEC)
- The filing relates to the healthcare stock’s proposed initial US public offering of American Depositary Shares (ADS), with each ADS potentially worth 9 AHI listed shares
- The company would list on the NASDAQ Capital Market under the ticker code AHI, with each ADS to be sold at between US$7 and US$9 each based on the 1 for 9 ratio
- AHI will begin selling the NASDAQ securities once its registration is accepted by the SEC, which hasn’t occurred at this stage
- Shares in Advanced Human Imaging are trading up 3.52 per cent at $1.18
Advanced Human Imaging (AHI) is pushing ahead with a planned NASDAQ listing, after filing a key form with the US Securities and Exchange Commission (SEC).
AHI announced on Wednesday it had submitted a Form F-1 to the SEC in relation to the proposed initial US public offering of American Depositary Shares (ADS).
Each ADS will represent a set number of ordinary AHI shares, though the exact amount is yet to be determined. However, a rough estimate released by the company is that 1 ADS would be worth around 9 AHI securities.
Under the proposed offering, each ADS would be priced at between US$7 and US$9 each and the company would list on the NASDAQ Capital Market under the ticker code AHI.
The healthcare stock will begin selling the NASDAQ securities once its registrations has been accepted by the SEC, which hasn’t occurred at this stage.
The offering will be made via a prospectus and Maxim Group LLC will act as the sole book-running manager under the listing.
Advanced Human Imaging first flagged plans to dual list in the US last year when it signed a funding agreement with Asia Cornerstone Asset Management
Following today’s NASDAQ update, shares in AHI have moved 3.52 per cent in the green to $1.18 per share at 1:47 pm AEDT.